Dual Epidermal Growth Factor Receptor Inhibition With Erlotinib and Panitumumab With or Without Chemotherapy for Advanced Colorectal Cancer
Clinical trial NCT00940316 · COMPLETED
Trial details
- NCT number
- NCT00940316
- Sponsor
- Northwestern University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-18
- Primary completion
- 2015-01-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.